Affluent Medical : 2022 financial communication calendar
|
Affluent Medical PRESS RELEASE Aix-en-Provence, 24 January 2022 - 5:45 PM
2022 financial communication calendar
Affluent Medical (ISIN code: FR0013333077 - mnemonic: AFME), a French medtech specialised in the international development and industrialisation of innovative medical prostheses - at a clinical stage - to treat urinary incontinence and the pathology of the heart mitral valve, today is announcing its 2022 financial communication calendar.
Publication of financial statements as of December 31, 2021
Publication of financial statements as of June 30, 2022
All communications are published after market close. This schedule is provided for information purposes only and may change.
About Affluent Medical Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the preclinical and clinical study phase. The first medical device should be marketed in Europe with Kalios. For more information, please visit: www.affluentmedical.com
Contacts:
Regulatory filing PDF file File: 2022 financial communication calendar |
| Language: | English |
| Company: | Affluent Medical |
| 320 avenue Archimède, Les pléiades III Bâtiment B | |
| 13100 Aix en Provence France | |
| France | |
| Phone: | +33 4 42 95 12 20 |
| E-mail: | [email protected] |
| Internet: | https://www.affluentmedical.com/ |
| ISIN: | FR0013333077 |
| Euronext Ticker: | AFME |
| AMF Category: | Inside information / Issuer activities (acquisitions, sales...) |
| EQS News ID: | 1272179 |
| End of Announcement | EQS News Service |
1272179 24-Jan-2022 CET/CEST
